Ligand Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LGND and other ETFs, options, and stocks.

About LGND

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV.

CEO

Todd C. Davis

CEOTodd C. Davis

Employees

Employees58

Headquarters

Jupiter, Florida

HeadquartersJupiter, Florida

Founded

1987

Founded1987

Employees

Employees58

LGND Key Statistics

Market cap

1.33B

Market cap1.33B

Price-Earnings ratio

25.16

Price-Earnings ratio25.16

Dividend yield

—

Dividend yield—

Average volume

145.97K

Average volume145.97K

High today

$74.17

High today$74.17

Low today

$72.57

Low today$72.57

Open price

$73.53

Open price$73.53

Volume

140.73K

Volume140.73K

52 Week high

$94.57

52 Week high$94.57

52 Week low

$49.24

52 Week low$49.24

LGND News

Benzinga 2d

Options Exercise Update At Ligand Pharmaceuticals: Jason Aryeh Engages - Ligand Pharmaceuticals - Benzinga

Loading... Loading... A large exercise of company stock options by Jason Aryeh, Director at Ligand Pharmaceuticals LGND was disclosed in a new SEC filing on Ma...